# US 2025/0375548 A1 · Sterilization process, system and product including molecular mobility enhancer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0375548 A1
- Document ID: US20250375548A1
- Status: Published application
- Kind: A1
- Application number: 18/999,930
- Filed: 2024-12-23
- Published: 2025-12-11
- Earliest claimed: 2019-01-28
- Assignees: Tekdry International, Inc.
- Applicants: Tekdry International, Inc.
- Inventors: Daniel STOREY; Christina K. THOMAS
- Web page: https://patentgrep.com/patent/US20250375548A1

## CPC

- A61B 1/123: {using washing machines}
- A61L 2/208: Hydrogen peroxide
- A01N 25/08: containing solids as carriers or diluents
- A01N 37/16: containing the group [IMAGE cpc-sch-A01N-0934.gif]; Thio analogues thereof
- A01N 59/00: Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01P 1/00: Disinfectants; Antimicrobial compounds or mixtures thereof
- A61L 2103/15: Laboratory, medical or dentistry appliances, e.g. catheters or sharps
- A61L 2103/50: Textiles, e.g. bedwear or towels
- A61L 2202/11: Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps
- A61L 2202/122: Chambers for sterilisation
- A61L 2202/14: Means for controlling sterilisation processes, data processing, presentation and storage means, e.g. sensors, controllers, programs
- A61L 2202/18: Aseptic storing means
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01P: BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS

## Abstract

Methods for generating a sterilant vapor in a sub-atmospheric environment for use in sanitization and sterilization. The vapor is generated from a mixture containing a sterilant and a molecular mobility enhancer (MME). More specifically, the use of the MME enhances the vaporization and mobility of the sterilant, particularly hydrogen peroxide and/or a peroxy acid, to provide enhanced or improved sterilization. Also provided are solid-form sterilant comprising a sterilant and an MME. Further provides are various packaged forms of sterilant, particularly containing hydrogen peroxide and/or a peroxy acid for use in sanitation and sterilization methods herein.

## Claims

### Claim at position 1

-84. (canceled)

### Claim 85

A method of sterilizing an article by contacting the article with a vapor comprising a sterilant and a molecular mobility enhancer (MME) under vacuum at a selected pressure of the vapor for a selected time.

### Claim 86 (depends on 85)

The method of claim 85, wherein the sterilant is a liquid at normal temperature and pressure (NPT, 20° C. and 760 torr).

### Claim 87 (depends on 85)

The method of claim 85, wherein the MME is a liquid at normal temperature and pressure (NPT, 20° C. and 760 torr).

### Claim 88 (depends on 85)

The method of claim 85, wherein the molecular mobility enhancer is one or more of an alcohol, alkane, carboxylic acid, ester, ether, ketone and any combination thereof.

### Claim 89 (depends on 85)

The method of claim 85, wherein the molecular mobility enhancer is one or more of: a C1-C20 alcohol, a C5-C20 alkane, a C1-C20 carboxylic acid, a C3-C20 ester, a C4-C20 ether, a C3-C20 ketone and any combination thereof.

### Claim 90 (depends on 85)

The method of claim 85, wherein the molecular mobility enhancer has a vapor pressure equal to or greater than 100 torr at 20° C. and 760 torr.

### Claim 91 (depends on 85)

The method of claim 85, wherein the sterilant comprises hydrogen peroxide, a peroxy acid, a halogenated peroxy acid, a carboxylic acid, or an alcohol or any combination thereof.

### Claim 92

A solid-form sterilant, comprising
a sterilant matrix;
a sterilant compound encapsulated within the sterilant matrix; and
a molecular mobility enhancing (MME) agent encapsulated within the sterilant matrix.

### Claim 93 (depends on 92)

The solid-form sterilant of claim 92, wherein the sterilant compound is selected from the group consisting of an acid, an alcohol, hydrogen peroxide, glutaraldehyde, ortho-phthaladehyde, and combinations thereof.

### Claim 94 (depends on 93)

The solid-form sterilant of claim 93, wherein the sterilant compound is selected from the group consisting of a peri-peroxy acid, a phenolic acid, hypochlorous acid, isopropanol, hydrogen peroxide, glutaraldehyde, ortho-phthaladehyde, and combinations thereof.

### Claim 95 (depends on 93)

The solid-form sterilant of claim 93, wherein the sterilant compound is a peri-peroxy acid selected from the group consisting of performic acid, a peroxy acid, and combinations thereof.

### Claim 96 (depends on 95)

The solid-form sterilant of claim 95, where the peroxy acid is selected from the group consisting of saturated and unsaturated peroxy acids having between 1 and 8 carbon atoms and including any halogenated forms of the peroxy acids.

### Claim 97 (depends on 95)

The solid-form sterilant of claim 95, where the peroxy acid is selected from the group consisting of peroxyacetic acid and its halogenated derivatives, peroxypropionic acid, and its halogenated derivatives and peroxybutyric acid and its halogenated derivatives.

### Claim 98 (depends on 95)

The solid-form sterilant of claim 95, wherein the MME agent is selected from the group consisting of an ether, an alcohol, a phenol, an ester and an amide.

### Claim 99 (depends on 92)

The solid-form sterilant of claim 92, wherein the sterilant matrix comprises a matrix material selected from the group consisting of a polymer, a ceramic, a glass, and combinations thereof.

### Claim 100 (depends on 92)

A packaged sterilant for use in a vacuum environment, comprising the solid-form sterilant of claim 92 within a package.

### Claim 101

A method for providing a sterilant to an enclosure, the method comprising: exposing a mixture comprising a molecular mobility enhancer (MME) and the sterilant to the enclosure at a sub-atmospheric pressure condition, thereby providing the sterilant as a vapor in the enclosure.

### Claim 102 (depends on 101)

The method of claim 101, wherein the mixture is a solid-form sterilant, comprising
a sterilant matrix;
a sterilant compound encapsulated within the sterilant matrix; and
a molecular mobility enhancing (MME) agent encapsulated within the sterilant matrix.

### Claim 103 (depends on 101)

The method of claim 101, wherein the enclosure is within an apparatus capable of achieving reduced pressure, and wherein the method comprises:
introducing a mixture of the sterilant and the molecular mobility enhancer into the apparatus, and
reducing the pressure in at least a portion of the apparatus to generate a vapor comprising sterilant in at least a portion of the apparatus.

### Claim 104 (depends on 103)

The method of claim 103, wherein an article to be treated is present in the apparatus and the vapor generated is in contact with the article.
